Advertisement
Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal

Prevention of Fibrosis Progression in CCl4-Treated Rats: Role of the Hepatic Endocannabinoid and Apelin Systems

Vedrana Reichenbach, Josefa Ros, Guillermo Fernández-Varo, Gregori Casals, Pedro Melgar-Lesmes, Teresa Campos, Alexandros Makriyannis, Manuel Morales-Ruiz and Wladimiro Jiménez
Journal of Pharmacology and Experimental Therapeutics March 2012, 340 (3) 629-637; DOI: https://doi.org/10.1124/jpet.111.188078
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal

Fibrosis Progression Prevention in CCl4-Treated Rats

Vedrana Reichenbach, Josefa Ros, Guillermo Fernández-Varo, Gregori Casals, Pedro Melgar-Lesmes, Teresa Campos, Alexandros Makriyannis, Manuel Morales-Ruiz and Wladimiro Jiménez
Journal of Pharmacology and Experimental Therapeutics March 1, 2012, 340 (3) 629-637; DOI: https://doi.org/10.1124/jpet.111.188078
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement